Lewandowski v. Johnson & Johnson

On July 17, 2026, WLF asked the Third Circuit to affirm the dismissal of an ERISA class action that challenges prescription drug prices inside a self-funded health plan. In its amicus brief, WLF contends that a participant who received every benefit her plan promised suffers no concrete injury from wishing one line item had cost less, and that such suits would deter employers from sponsoring coverage at all. The National Association of Manufacturers joined WLF on the brief.